Literature DB >> 18383036

Proliferation and interleukin 5 production by CD8hi CD57+ T cells.

Lee K Chong1, Rebecca J Aicheler, Sian Llewellyn-Lacey, Peter Tomasec, Paul Brennan, Eddie C Y Wang.   

Abstract

CD8hi CD57+ T cells have previously been described as effector memory T cells with minimal expansion capacity and high susceptibility to activation-induced cell death. In contrast, we demonstrate here that CD8hi CD57+ T cells are capable of rapid expansion using multiple techniques including [(3)H]thymidine uptake, flow cytometric bead-based enumeration and standard haemocytometer counting. Previous reports can be explained by marked inhibition of activation-induced expansion and increased 7-amino-actinomycin D uptake by CD8hi CD57+ T cells following treatment with CFSE, a dye previously used to measure their proliferation, combined with specific media requirements for the growth of this cell subset. The ability of CD8hi CD57+ T cells to further differentiate is highlighted by a distinct cytokine profile late after activation that includes the unexpected release of high levels of interleukin 5. These data indicate that CD8hi CD57+ T cells should not be considered as "end-stage" effector T cells incapable of proliferation, but represent a highly differentiated subset capable of rapid division and exhibiting novel functions separate from their previously described cytotoxic and IFN-gamma responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383036      PMCID: PMC2843081          DOI: 10.1002/eji.200737687

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Flow cytometry-based methods for apoptosis detection in lymphoid cells.

Authors:  Owen Williams
Journal:  Methods Mol Biol       Date:  2004

2.  New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy.

Authors:  S A Weston; C R Parish
Journal:  J Immunol Methods       Date:  1990-10-04       Impact factor: 2.303

3.  High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals.

Authors:  Yannick Le Priol; Denis Puthier; Cédric Lécureuil; Christophe Combadière; Patrice Debré; Catherine Nguyen; Béhazine Combadière
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

4.  Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population.

Authors:  M P Weekes; M R Wills; K Mynard; R Hicks; J G Sissons; A J Carmichael
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

5.  Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8+ T cell-APC conjugate formation and is associated with enhanced in vivo CTL function.

Authors:  Jean G Sathish; Garry Dolton; Frances G Leroy; R James Matthews
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 6.  Biological and molecular characteristics of interleukin-5 and its receptor.

Authors:  S Karlen; M L De Boer; R J Lipscombe; W Lutz; V A Mordvinov; C J Sanderson
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

7.  Comparison of three common amine reactive fluorescent probes used for conjugation to biomolecules by capillary zone electrophoresis.

Authors:  P R Banks; D M Paquette
Journal:  Bioconjug Chem       Date:  1995 Jul-Aug       Impact factor: 4.774

8.  Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes.

Authors:  W C Chan; S Link; A Mawle; I Check; R K Brynes; E F Winton
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

9.  An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients.

Authors:  B Sadat-Sowti; P Debré; L Mollet; L Quint; F Hadida; V Leblond; G Bismuth; B Autran
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

10.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

View more
  27 in total

1.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Suchitra Pandey; Vanessa A York; Janice Arakawa-Hoyt; Hanspeter Pircher; Philip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

2.  Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.

Authors:  Richard C Wu; Shujuan Liu; Jessica A Chacon; Sheng Wu; Yufeng Li; Pariya Sukhumalchandra; James L Murray; Jeffrey J Molldrem; Patrick Hwu; Hanspeter Pircher; Gregory Lizée; Laszlo G Radvanyi
Journal:  Clin Cancer Res       Date:  2012-02-03       Impact factor: 12.531

3.  Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.

Authors:  A U Engela; C C Baan; N H R Litjens; M Franquesa; M G H Betjes; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

4.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 5.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

6.  Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis.

Authors:  Masanobu Tsuda; Yoko M Ambrosini; Weici Zhang; Guo-Xiang Yang; Yugo Ando; Guanghua Rong; Koichi Tsuneyama; Kosuke Sumida; Shinji Shimoda; Christopher L Bowlus; Patrick S C Leung; Xiao-Song He; Ross L Coppel; Aftab A Ansari; Zhe-Xiong Lian; M Eric Gershwin
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

7.  HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable.

Authors:  Stephen C De Rosa; Evan P Thomas; John Bui; Yunda Huang; Allan deCamp; Cecilia Morgan; Spyros A Kalams; Georgia D Tomaras; Rama Akondy; Rafi Ahmed; Chuen-Yen Lau; Barney S Graham; Gary J Nabel; M Juliana McElrath
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

Review 8.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.

Authors:  Ebba Sohlberg; Shanie Saghafian-Hedengren; Eahsan Rasul; Giovanna Marchini; Caroline Nilsson; Eva Klein; Noémi Nagy; Eva Sverremark-Ekström
Journal:  J Immunol       Date:  2013-10-18       Impact factor: 5.422

10.  Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis.

Authors:  R García-Muñoz; P Rodríguez-Otero; A Galar; J Merino; J J Beunza; J A Páramo; R Lecumberri
Journal:  Adv Hematol       Date:  2009-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.